OBJECTIVE: The management of drug-drug interactions (DDIs) involves a complex risk-benefit assessment, in which patients' preferences should be taken into account. The aim of this study was to examine the aspects influencing patients' preferences with regard to DDI management options. METHODS: A qualitative study consisting of five focus groups with patients chronically using cardiovascular drugs was conducted. Key questions concerned preferences regarding DDI management options for a provided fictitious DDI. Thematic analysis of the verbatim transcripts was performed. RESULTS: Despite their limited knowledge with respect to DDIs, patients easily chose a management option for the presented DDI. When additional information was provided, pref...
Relevancy of potential drug-drug interactions (pDDIs) is crucial in alerting system design. However,...
Potentially inappropriate medications are associated with polypharmacy and polypathology. Some inter...
Objective: Adverse drug events relating to drug-drug interactions are a common cause of patient harm...
OBJECTIVE: The management of drug-drug interactions (DDIs) involves a complex risk-benefit assessmen...
INTRODUCTION: The management of drug-drug interactions (DDIs) is a complex process in which risk-ben...
INTRODUCTION: The management of drug-drug interactions (DDIs) is a complex process in which risk-ben...
Introduction The management of drug-drug interactions (DDIs) is a complex process in which risk-bene...
Background For the management of drug-drug interactions (DDI), a risk-benefit assessment should be c...
Aim: Although drug-drug interactions (DDIs) cause major adverse drug reactions (ADRs) in patients un...
AIM: The aim of this study was to identify patient preferences for involvement in medication managem...
Introduction: There is a growing trend of using patient preference studies to help incorporate the p...
0Background/aim: Drug drug interactions (DDIs) can impact patient safety. Occurrence of clinically i...
Objective. Studies have shown that increasing patient participation in decision making decreases uti...
Objectives: This study investigated patients' preferences for an innovative combined prescribing-and...
Objectives To explore what considerations patients have when deciding about disease-modifying anti-r...
Relevancy of potential drug-drug interactions (pDDIs) is crucial in alerting system design. However,...
Potentially inappropriate medications are associated with polypharmacy and polypathology. Some inter...
Objective: Adverse drug events relating to drug-drug interactions are a common cause of patient harm...
OBJECTIVE: The management of drug-drug interactions (DDIs) involves a complex risk-benefit assessmen...
INTRODUCTION: The management of drug-drug interactions (DDIs) is a complex process in which risk-ben...
INTRODUCTION: The management of drug-drug interactions (DDIs) is a complex process in which risk-ben...
Introduction The management of drug-drug interactions (DDIs) is a complex process in which risk-bene...
Background For the management of drug-drug interactions (DDI), a risk-benefit assessment should be c...
Aim: Although drug-drug interactions (DDIs) cause major adverse drug reactions (ADRs) in patients un...
AIM: The aim of this study was to identify patient preferences for involvement in medication managem...
Introduction: There is a growing trend of using patient preference studies to help incorporate the p...
0Background/aim: Drug drug interactions (DDIs) can impact patient safety. Occurrence of clinically i...
Objective. Studies have shown that increasing patient participation in decision making decreases uti...
Objectives: This study investigated patients' preferences for an innovative combined prescribing-and...
Objectives To explore what considerations patients have when deciding about disease-modifying anti-r...
Relevancy of potential drug-drug interactions (pDDIs) is crucial in alerting system design. However,...
Potentially inappropriate medications are associated with polypharmacy and polypathology. Some inter...
Objective: Adverse drug events relating to drug-drug interactions are a common cause of patient harm...